Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma.

Wang MT, Chen G, An SJ, Chen ZH, Huang ZM, Xiao P, Ben XS, Xie Z, Chen SL, Luo DL, Tang JM, Lin JY, Zhang XC, Wu YL.

Dis Esophagus. 2012 Sep-Oct;25(7):664-70. doi: 10.1111/j.1442-2050.2011.01291.x. Epub 2011 Dec 9.

PMID:
22150974
2.

Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.

Nakamura T, Ide H, Eguchi R, Hayashi K, Takasaki K.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1321-6.

PMID:
14571727
3.

Cyclin D1 expression and retinoblastoma gene protein (pRB) expression in esophageal squamous cell carcinoma.

Ikeguchi M, Sakatani T, Ueta T, Kaibara N.

J Cancer Res Clin Oncol. 2001 Sep;127(9):531-6.

PMID:
11570573
5.

CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.

Seiler R, Thalmann GN, Rotzer D, Perren A, Fleischmann A.

Mod Pathol. 2014 Jan;27(1):87-95. doi: 10.1038/modpathol.2013.125. Epub 2013 Jul 26.

6.

Retinoblastoma-protein (prb) expression and prognosis in squamous-cell carcinomas of the esophagus.

zur Hausen A, Sarbia M, Heep H, Willers R, Gabbert HE.

Int J Cancer. 1999 Dec 22;84(6):618-22.

7.

Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression.

Fukuchi M, Fukai Y, Kimura H, Sohda M, Miyazaki T, Nakajima M, Masuda N, Tsukada K, Kato H, Kuwano H.

Int J Oncol. 2006 Aug;29(2):329-34.

PMID:
16820873
8.

Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.

Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM.

J Pathol. 2009 Mar;217(4):516-23. doi: 10.1002/path.2462.

PMID:
18991334
9.

Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma.

Li H, Xiao W, Ma J, Zhang Y, Li R, Ye J, Wang X, Zhong X, Wang S.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):7989-98. eCollection 2014.

10.

Clinical significance of retinoblastoma protein (pRB) expression in esophageal squamous cell carcinoma.

Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N.

J Surg Oncol. 2000 Feb;73(2):104-8.

PMID:
10694647
11.

Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma.

Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, Shintaku M, Yamashita T, Hiai H, Fukumoto M.

Int J Cancer. 1997 Dec 19;74(6):576-81.

12.

Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma.

Shiozaki A, Nakashima S, Ichikawa D, Fujiwara H, Konishi H, Komatsu S, Kubota T, Okamoto K, Iitaka D, Shimizu H, Nako Y, Takemoto K, Kishimoto M, Otsuji E.

Anticancer Res. 2013 Oct;33(10):4329-35.

PMID:
24123000
13.

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays.

Bièche I, Olivi M, Noguès C, Vidaud M, Lidereau R.

Br J Cancer. 2002 Feb 12;86(4):580-6.

14.

Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population.

Mathew R, Arora S, Khanna R, Shukla NK, Mathur M, Ralhan R.

J Cancer Res Clin Oncol. 2001 Apr;127(4):251-7.

PMID:
11315260
15.

Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.

Güner D, Sturm I, Hemmati P, Hermann S, Hauptmann S, Wurm R, Budach V, Dörken B, Lorenz M, Daniel PT.

Int J Cancer. 2003 Feb 10;103(4):445-54.

16.

Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.

Miyamoto R, Uzawa N, Nagaoka S, Hirata Y, Amagasa T.

Oral Oncol. 2003 Sep;39(6):610-8.

PMID:
12798405
17.

Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer.

Itami A, Shimada Y, Watanabe G, Imamura M.

Oncology. 1999 Nov;57(4):311-7.

PMID:
10575318
18.

High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.

Zaharieva BM, Simon R, Diener PA, Ackermann D, Maurer R, Alund G, Knönagel H, Rist M, Wilber K, Hering F, Schönenberger A, Flury R, Jäger P, Fehr JL, Mihatsch MJ, Gasser T, Sauter G, Toncheva DI.

J Pathol. 2003 Dec;201(4):603-8.

PMID:
14648664
19.

Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.

Gupta VK, Feber A, Xi L, Pennathur A, Wu M, Luketich JD, Godfrey TE.

Clin Cancer Res. 2008 Dec 1;14(23):7804-12. doi: 10.1158/1078-0432.CCR-08-0744.

20.

A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.

Schneeberger C, Eder S, Swoboda H, Ullrich R, Zeillinger R.

Oral Oncol. 1998 Jul;34(4):257-60.

PMID:
9813719

Supplemental Content

Support Center